Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm   
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Europe
|
US/Canada
|
Japan
|
Asia (excluding Japan)
|
Latin America
|
Rest of World
|
International - Latin America
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK Promote your vacancy here
International formulations business drives Lupin to 21% growth
29 July 2010
Lupin has reported a 21% increase in net sales to Rs13.12 billion ($280.6 million) for the first quarter ended 30 June, led by strong growth in the formulations business in the US and Europe. Net profit rose by 40% to Rs1.96 billion. US and Europe ...
Masters announces £2.7 million investment and Burns appointment
25 June 2010
Masters Pharmaceuticals, a UK-based healthcare solutions provider specialising in named patient/expanded access programmes for discontinued products, orphan drugs and medicines in clinical development, has secured a £2.65 million investment from ...
US report finds flaws in FDA oversight of foreign clinical trials
23 June 2010
The US Department of Health and Human Services has called for the Food and Drug Administration to improve its oversight of foreign clinical trial data after finding that sponsors rely "heavily" on such data to support their marketing applications ...
GSK pays $253 million for Argentinian generics firm
11 June 2010
GlaxoSmithKline has acquired the Argentinian branded generics company Laboratories Phoenix for $253 million in cash. GSK's position in the Argentinian pharmaceutical market will increase from 14th to third after the acquisition. Phoenix, with 2009 ...
EU looks to "pharmerging" markets for trade boost while FTA talks with Central America stumble
12 May 2010
The European Commission is to relaunch free-trade agreement (FTA) negotiations with Mercosur, the "Common Market of the South" (ie, Argentina, Brazil, Paraguay and Uruguay), as trade talks with Central America seem to have stalled. The ...
 
2010 Scrip 100 - Pharma muscles into emerging markets with M&A
23 August 2010
This year has seen many firms facing patent expiries on core revenue generators. The current climate is driving M&A strategies, particularly in emerging markets and often with a focus on branded ...
The European Union: pursuing IPRs at any cost?
02 June 2010
Europe stands accused of jeopardising access to affordable, life-saving drugs in developing countries as it pursues intellectual property rights for pharmaceuticals. Francesca Bruce takes a look at ...
2010 Scrip 100 - Argentina biotech: time to invest?
09 December 2009
Argentinian firms have a surprising amount of expertise in the field of biosimilars, while a strong science base has fed healthy demand for locally manufactured products. Can the country elevate its ...
 
Interview: European Medicines Agency gets serious about its global strategy
29 January 2010
Developing relationships with medicine regulators in China and India is just one of the challenges facing Emer Cooke, the international face of the European Medicines Agency (EMA), Scrip's Elizabeth ...
Face to face: Finding solace in emerging markets
28 January 2009
As I approach Hákan Björklund, his irritability becomes increasingly apparent. Sitting in a brown leather chair, the Swedish CEO of Nycomed mutters "this simply won't do", gesturing towards the ...
 
Emerging markets: a clearer categorisation needed
30 November 2009
Emerging markets are a popular topic at the moment, with pharma firms seeking sales growth outside the mature and slowing markets of the west. There are some companies with a long history of ...
The frustration of high medicine prices
04 September 2009
There are ongoing concerns about the high price of medicines in developing countries. Two recent surveys, taken in Vietnam and Thailand, show that medicines in the public and private sectors are ...
 
COMPANY/ORGANISATION
CONDITION
GEOGRAPHY
DRUG
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm